Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Depreciation & Amortization (CF) (2016 - 2025)

Mesa Laboratories' Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 14.83% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $5.3 million, up 28.44%, while the annual FY2025 figure was $5.4 million, 77.57% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $1.3 million at Mesa Laboratories, down from $1.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $9.4 million in Q1 2022 and bottomed at $132000.0 in Q1 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $4.4 million (2021), against an average of $4.5 million.
  • The largest annual shift saw Depreciation & Amortization (CF) plummeted 98.54% in 2024 before it soared 925.76% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $6.8 million in 2021, then grew by 25.49% to $8.6 million in 2022, then plummeted by 87.48% to $1.1 million in 2023, then grew by 2.98% to $1.1 million in 2024, then grew by 14.83% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Depreciation & Amortization (CF) are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.4 million (Q2 2025).